Thomas Engstrand

Thomas Engstrand

Auto-generated profile, based on publicly available information

Thomas Engstrand

Stockholm Craniofacial Centre, Department of Molecular Medicine and Surgery, Plastic Surgery Section, Karolinska University Hospital and Karolinska Institutet, 17176 Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
OOOmar Omar
Omar Omar
TEThomas Engstrand
Thomas Engstrand
LLLars Kihlström Burenstam Linder
Lars Kihlström Burenstam Linder
JÅJonas Åberg
Jonas Åberg
Furqan ShahFurqan Shah
Furqan Shah
Peter ThomsenPeter Thomsen
Peter Thomsen
Significance: Large cranial reconstructions are increasingly performed worldwide and still represent a substantial clinical challenge. The gold standard, autologous bone, has limited availability and high donor-site morbidity. Current alloplastic materials are associated with high complication and failure rates. This study shows the capacity of a customized, purely synthetic, 3D-manufactured bioceramic implant to regenerate and restore large cranial defects with mature, well-vascularized bone, with a morphology, ultrastructure, and composition similar to those of native skull bone. This approach triggers the regenerative potential of host tissue by tailoring the implant composition and design. The regeneration of large defects using purely synthetic material without adjunct cell therapy or growth factors represents a major advancement for rehabilitating patients in need of large cranial reconstructions.

1 January 2013 in Laboratory Animals
Verified
Journal Article
Open access
CACecilia Aulin
Cecilia Aulin
MJM Jensen-Waern
M Jensen-Waern
SES Ekman
S Ekman
MHM Hägglund
M Hägglund
TET Engstrand
T Engstrand
PHPatricia Hedenqvist
Patricia Hedenqvist
Articular cartilage has a limited capacity for self-repair in adult humans, and methods used to stimulate regeneration often result in re-growth of fibrous cartilage, which has lower durability. No current treatment option can provide complete repair. The possibility of growth factor delivery into the joint for cartilage regeneration after injury would be an attractive treatment option. A full thickness osteochondral defect of 4 mm in diameter and 2 mm deep was created by mechanical drilling in the medial femoral condyle in 20 female adult New Zealand White rabbits. In an attempt to improve regeneration a hyaluronic hydrogel system, with or without bone morphogenetic protein-2 (BMP-2) was delivered intraarticularly. The contralateral joint defect was treated with saline as control. Throughout the study, rabbits were clinically examined and after 12 (n = 6) or 24 (n = 9) weeks, the rabbits were euthanized and the joints evaluated by histology. The defects healed with fibrocartilage like tissue, and the filling of the defects ranged from less than 25% to complete. The healing of the defects varied both inter- and intra-group wise. Treatment with hyaluronan gel with or without BMP-2 had no effect on cartilage regeneration compared with controls. Instead, severe ectopic bone formation was found in seven joints treated with BMP-2. In conclusion, the present study shows that neither treatment with hyaluronic gel alone, nor in combination with BMP-2, improves the healing of an induced cartilage defect in rabbits. It further shows that BMP-2 can induce ectopic bone formation, which severely affects the functionality of the joint.